CSIMarket
 


Evolutionary Genomics Inc   (FNAM)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

FNAM's Operating Income Growth by Quarter and Year

Evolutionary Genomics Inc 's Operating Income results by quarter and year




FNAM Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -1.34 -0.47 -0.16
III Quarter September -0.55 -0.55 -0.31 -0.17
II Quarter June -0.53 -0.51 -0.23 -0.21
I Quarter March -0.52 -1.86 -0.23 -0.18
FY   -1.60 -4.26 -1.24 -0.72



FNAM Operating Income third quarter 2022 Y/Y Growth Comment
Evolutionary Genomics Inc in the third quarter 2022 recorded Operating Loss of $ -0.55 millions.

According to the results reported in the third quarter 2022, Evolutionary Genomics Inc achieved the best Operating Income growth in Medical Laboratories industry. While Evolutionary Genomics Inc ' s Operating Income no change of % ranks overall at the positon no. in the third quarter 2022.

Explain Operating Income growth


FNAM Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Evolutionary Genomics Inc 's third quarter 2022 Operating Income $ -0.55 millions FNAM's Income Statement
Evolutionary Genomics Inc 's third quarter 2021 Operating Income $ -0.55 millions Quarterly FNAM's Income Statement
New: More FNAM's historic Operating Income Growth >>


FNAM Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Evolutionary Genomics Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FNAM's III. Quarter Q/Q Operating Income Comment
III. Quarter 2022 results of -0.55 millions by Evolutionary Genomics Inc look even less good compare to the -0.53 millions a quarter before.

Within Medical Laboratories industry Evolutionary Genomics Inc achieved highest sequential Operating Income growth. While Evolutionary Genomics Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FNAM's III. Quarter Q/Q Operating Income Comment
III. Quarter 2022 results of -0.55 millions by Evolutionary Genomics Inc appear even more unfavourable if you take a look at -0.53 millions in the previous quarter.

Within Medical Laboratories industry Evolutionary Genomics Inc achieved highest sequential Operating Income growth. While Evolutionary Genomics Inc 's Operating Income growth quarter on quarter, overall rank is .


Evolutionary Genomics Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Jun 30 2021)
Cumulative Operating Income 12 Months Ending $ -2.94 $ -2.95 $ -2.93 $ -4.27 $ -3.41
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Evolutionary Genomics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Evolutionary Genomics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Medical Laboratories Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
FNAM's Operating Income Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for FNAM's Competitors
Operating Income Growth for Evolutionary Genomics Inc 's Suppliers
Operating Income Growth for FNAM's Customers

You may also want to know
FNAM's Annual Growth Rates FNAM's Profitability Ratios FNAM's Asset Turnover Ratio FNAM's Dividend Growth
FNAM's Roe FNAM's Valuation Ratios FNAM's Financial Strength Ratios FNAM's Dividend Payout Ratio
FNAM's Roa FNAM's Inventory Turnover Ratio FNAM's Growth Rates FNAM's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2022
Zoetis Inc -0.28%$ -0.278 millions
Taitron Components Incorporated-2.81%$ -2.813 millions
Charles River Laboratories International inc -3.10%$ -3.098 millions
Sotera Health Company-3.77%$ -3.770 millions
Encompass Health Corporation-3.92%$ -3.919 millions
Abiomed Inc -4.04%$ -4.041 millions
Owens and Minor Inc -4.18%$ -4.180 millions
Amphastar Pharmaceuticals Inc -6.22%$ -6.221 millions
Phibro Animal Health Corporation-6.35%$ -6.351 millions
Boston Scientific Corporation-7.49%$ -7.494 millions
Conmed Corporation-9.22%$ -9.221 millions
Intuitive Surgical Inc -9.87%$ -9.873 millions
Cadre Holdings inc -10.60%$ -10.605 millions
Eli Lilly And Company-10.88%$ -10.881 millions
Bio techne Corp-10.92%$ -10.922 millions
Corcept Therapeutics Inc-11.86%$ -11.862 millions
U S Physical Therapy Inc-12.03%$ -12.030 millions
Universal Health Services Inc -12.37%$ -12.366 millions
Semler Scientific inc -14.96%$ -14.963 millions
National Research Corporation-15.44%$ -15.444 millions
Lhc Group Inc-15.76%$ -15.758 millions
Reynolds Consumer Products Inc -16.19%$ -16.190 millions
Merck and Co Inc -16.69%$ -16.694 millions
Zynex inc -18.49%$ -18.494 millions
Pediatrix Medical Group Inc -19.40%$ -19.400 millions
Molecular Templates Inc -19.85%$ -19.852 millions
Kintara Therapeutics Inc -22.19%$ -22.191 millions
Tenax Therapeutics Inc -23.27%$ -23.270 millions
Alpha Pro Tech Ltd -23.79%$ -23.793 millions
Maravai Lifesciences Holdings Inc -25.48%$ -25.479 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LRDC's Profile

Stock Price

LRDC's Financials

Business Description

Fundamentals

Charts & Quotes

LRDC's News

Suppliers

LRDC's Competitors

Customers & Markets

Economic Indicators

LRDC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071